Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin
Status:
Not yet recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety of selective transarterial chemoembolization
(TACE) of hepatocellular carcinoma (HCC) in the setting of an elevated total bilirubin, but
relatively normal direct bilirubin.
Phase:
Phase 1
Details
Lead Sponsor:
University of Minnesota - Clinical and Translational Science Institute